Literature DB >> 9506618

Clusters of microembolic signals: a new form of cerebral microembolism presentation in a patient with middle cerebral artery stenosis.

T Segura1, J Serena, A Molíns, A Dávalos.   

Abstract

BACKGROUND: Middle cerebral artery (MCA) stenosis is a rare occlusive disease in western populations, with a high risk of stroke recurrence. An artery-to-artery embolic mechanism has been argued. We report the detection of a new pattern of microembolic signals (MES) in the MCA poststenotic segment in a patient with multiple recurrent transient ischemic attacks. CASE DESCRIPTION: A 75-year-old man was admitted to our hospital with a transient leg monoparesis on the left side. Right MCA stenosis was detected by transcranial Doppler ultrasonography (TCD). In spite of aspirin treatment, the patient had a recurrent right hemispheric transient ischemic attack, and anticoagulant therapy was started. A new, similar event happened after correct anticoagulation. The bigated TCD monitoring study of both MCAs disclosed clusters of MES at the poststenotic MCA segment. Each cluster contained between 12 and 45 embolic signals. The patient became asymptomatic and clusters of MES disappeared, coinciding with the combination of ticlopidine and oral anticoagulants.
CONCLUSIONS: We describe a new presentation of MES, ie, grouped in clusters of signals, that may be associated with a high risk of stroke recurrence.

Entities:  

Mesh:

Year:  1998        PMID: 9506618     DOI: 10.1161/01.str.29.3.722

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  2 in total

1.  Cessation of embolic signals after antithrombotic prevention is related to reduced risk of recurrent arterioembolic transient ischaemic attack and stroke.

Authors:  M Goertler; T Blaser; S Krueger; K Hofmann; M Baeumer; C W Wallesch
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

Review 2.  Pathological Characteristics.

Authors:  Xiang-Yan Chen; Mark Fisher
Journal:  Front Neurol Neurosci       Date:  2016-12-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.